Your browser doesn't support javascript.
loading
Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.
Portnoy, Allison; Pedersen, Kine; Trogstad, Lill; Hansen, Bo T; Feiring, Berit; Laake, Ida; Smith, Megan A; Sy, Stephen; Nygård, Mari; Kim, Jane J; Burger, Emily A.
Affiliation
  • Portnoy A; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA. Electronic address: aportnoy@mail.harvard.edu.
  • Pedersen K; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
  • Trogstad L; The Norwegian Institute of Public Health, Oslo, Norway.
  • Hansen BT; The Cancer Registry of Norway, Oslo, Norway.
  • Feiring B; The Norwegian Institute of Public Health, Oslo, Norway.
  • Laake I; The Norwegian Institute of Public Health, Oslo, Norway.
  • Smith MA; Daffodil Centre, The University of Sydney, A Joint Venture With Cancer Council NSW, Sydney, Australia.
  • Sy S; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA.
  • Nygård M; The Cancer Registry of Norway, Oslo, Norway.
  • Kim JJ; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA.
  • Burger EA; Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Boston, MA, USA; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Prev Med ; 150: 106688, 2021 09.
Article in En | MEDLINE | ID: mdl-34303489
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Health_economic_evaluation Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Prev Med Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Health_economic_evaluation Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: Prev Med Year: 2021 Type: Article